These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3584763)

  • 61. Serological response to trivalent inactivated influenza vaccine in HIV-infected adults in Singapore.
    Lau YF; Tang LH; Chien Lye D; Ooi EE; Leo YS
    Hum Vaccin Immunother; 2017 Mar; 13(3):551-560. PubMed ID: 28277090
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Safety and immunogenicity of a quadrivalent inactivated influenza vaccine in adults.
    Pépin S; Donazzolo Y; Jambrecina A; Salamand C; Saville M
    Vaccine; 2013 Nov; 31(47):5572-8. PubMed ID: 24016810
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Intradermally-administered influenza virus vaccine is safe and immunogenic in healthy adults 18-64 years of age.
    Gorse GJ; Falsey AR; Fling JA; Poling TL; Strout CB; Tsang PH
    Vaccine; 2013 May; 31(19):2358-65. PubMed ID: 23499604
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunogenicity and safety of an inactivated quadrivalent influenza vaccine in healthy adults: a phase II, open-label, uncontrolled trial in Japan.
    Tsurudome Y; Kimachi K; Okada Y; Matsuura K; Ooyama Y; Ibaragi K; Kino Y; Ueda K
    Microbiol Immunol; 2015 Oct; 59(10):597-604. PubMed ID: 26272602
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Phenytoin therapy and immune response to influenza vaccine.
    Levine M; Beattie BL; McLean DM; Corman D
    Clin Pharm; 1985; 4(2):191-4. PubMed ID: 3987219
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Increased serum HLA class I molecule levels in elderly human responders to influenza vaccination.
    Saririan K; Wali A; Almeida RP; Russo C
    Tissue Antigens; 1993 Jul; 42(1):9-13. PubMed ID: 8248895
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Humoral immune response after vaccination against influenza in patients with breast cancer.
    Brydak LB; Guzy J; Starzyk J; Machała M; Góźdź SS
    Support Care Cancer; 2001 Jan; 9(1):65-8. PubMed ID: 11147146
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Functional disability and antibody response to influenza vaccine in elderly patients in a Dutch nursing home.
    Remarque EJ; Cools HJ; Boere TJ; van der Klis RJ; Masurel N; Ligthart GJ
    BMJ; 1996 Apr; 312(7037):1015. PubMed ID: 8616350
    [No Abstract]   [Full Text] [Related]  

  • 69. Effect of dosage and influenza vaccine content on antibody response in an aged population.
    Saslaw S; Carlisle HN; Perkins RL
    Am J Med Sci; 1966 Feb; 251(2):195-206. PubMed ID: 5904738
    [No Abstract]   [Full Text] [Related]  

  • 70. Impact of host genetic polymorphisms on response to inactivated influenza vaccine in children.
    Tsang TK; Wang C; Tsang NNY; Fang VJ; Perera RAPM; Malik Peiris JS; Leung GM; Cowling BJ; Ip DKM
    NPJ Vaccines; 2023 Feb; 8(1):21. PubMed ID: 36804941
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Global analyses of human immune variation reveal baseline predictors of postvaccination responses.
    Tsang JS; Schwartzberg PL; Kotliarov Y; Biancotto A; Xie Z; Germain RN; Wang E; Olnes MJ; Narayanan M; Golding H; Moir S; Dickler HB; Perl S; Cheung F; ;
    Cell; 2014 Apr; 157(2):499-513. PubMed ID: 24725414
    [TBL] [Abstract][Full Text] [Related]  

  • 72. 'of Mice and men' (John steinbeck)-How do we determine the potential for immunotoxicity in humans?
    Burns C; Burns P; Holsapple M
    Ann Epidemiol; 2000 Oct; 10(7):471-472. PubMed ID: 11018404
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Safety and immunogenicity of trivalent inactivated influenza vaccine in adults 60 years of age and older: a phase II, a randomized, comparative trial in Kazakhstan.
    Sarsenbayeva G; Issagulov T; Kassenov M; Abitay R; Orynbayev M; Stukova M; Pisareva M; Davlyatshin T; Lespek K; Khairullin B
    Hum Vaccin Immunother; 2020 Aug; 16(8):1791-1797. PubMed ID: 32048890
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.
    Keitel WA; Jackson LA; Edupuganti S; Winokur PL; Mulligan MJ; Thornburg NJ; Patel SM; Rouphael NG; Lai L; Bangaru S; McNeal MM; Bellamy AR; Hill HR;
    J Infect Dis; 2015 Aug; 212(4):552-61. PubMed ID: 25649171
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.
    Frey SE; Bernstein DI; Brady RC; Keitel WA; El Sahly H; Rouphael NG; Mulligan MJ; Atmar RL; Edupuganti S; Patel SM; Dickey M; Graham I; Anderson EL; Noah DL; Hill H; Wolff M; Belshe RB
    Vaccine; 2015 Jan; 33(1):163-73. PubMed ID: 25444805
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Lack of persistence of influenza vaccine antibody titers in patients with heart failure.
    Albrecht CM; Sweitzer NK; Johnson MR; Vardeny O
    J Card Fail; 2014 Feb; 20(2):105-9. PubMed ID: 24361852
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Age and psychological influences on immune responses to trivalent inactivated influenza vaccine in the meditation or exercise for preventing acute respiratory infection (MEPARI) trial.
    Hayney MS; Coe CL; Muller D; Obasi CN; Backonja U; Ewers T; Barrett B
    Hum Vaccin Immunother; 2014; 10(1):83-91. PubMed ID: 24096366
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Double dose vs. standard dose influenza vaccination in patients with heart failure: a pilot study.
    Van Ermen A; Hermanson MP; Moran JM; Sweitzer NK; Johnson MR; Vardeny O
    Eur J Heart Fail; 2013 May; 15(5):560-4. PubMed ID: 23291729
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Decreased T-cell responses to influenza vaccination in patients with heart failure.
    Vardeny O; Moran JJ; Sweitzer NK; Johnson MR; Hayney MS
    Pharmacotherapy; 2010 Jan; 30(1):10-6. PubMed ID: 20030468
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of annual influenza immunization on antibody response in lung transplant patients.
    Dopp JM; Wiegert NA; Moran JJ; Francois ML; Radford KL; Thomas H; Love RB; Hayney MS
    Prog Transplant; 2009 Jun; 19(2):153-9. PubMed ID: 19588665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.